Results 311 to 320 of about 299,239 (347)

EudraVigilance insights: Suspected adverse drug reactions in infants through breastfeeding

British Journal of Clinical Pharmacology, EarlyView.
Aims We aimed to describe suspected adverse drug reactions (ADRs) in infants resulting from medications transmitted through mothers' milk, as reported to the European ADR database, EudraVigilance. The research sought to understand the frequency, seriousness and nature of these ADRs to assess potential risks associated with maternal medication use ...
Ida M. Heerfordt, Ditte Resendal Gotfredsen, Henrik Horwitz, Anette Kirstine Stark, Jon Trærup Andersen, Christina Gade, Ulrik Lausten‐Thomsen, Rasmus Huan Olsen   +7 more
wiley   +1 more source

Drug treatments for mild or moderate covid-19: systematic review and network meta-analysis.

BMJ
Ibrahim S, Siemieniuk RAC, Oliveros MJ, Islam N, Díaz Martinez JP, Izcovich A, Qasim A, Zhao Y, Zaror C, Yao L, Wang Y, Vandvik PO, Roldan Y, Rochwerg B, Rada G, Prasad M, Pardo-Hernandez H, Mustafa RA, Fashami FM, Miroshnychenko A, McLeod SL, Mansilla C, Lamontagne F, Khosravirad A, Honarmand K, Ghadimi M, Gao Y, Foroutan F, Devji T, Couban R, Chu DK, Chowdhury SR, Chang Y, Bravo-Soto G, Bosio C, Biscay D, Bhogal G, Azab M, Agoritsas T, Agarwal A, Guyatt GH, Brignardello-Petersen R.   +41 more
europepmc   +1 more source

Assessment of COVID-19 hospitalisation cost and its associated factors in Nepal: a descriptive cross-sectional study. [PDF]

BMJ Open
Acharya Y, Paudel P, Regmi U, Paneru B, Shrestha A, Karmacharya BM.   +5 more
europepmc   +1 more source

Developing the Inpatient Mental Health Pharmaceutical Assessment and Care Tool (IMPACT) for use by UK mental health pharmacy teams—a modified Delphi study

British Journal of Clinical Pharmacology, EarlyView.
Aims To develop an evidence‐ and consensus‐based patient prioritization tool for use by UK mental health inpatient pharmacy teams. Methods A modified‐Delphi technique was used to obtain experts' agreement on the content, design and practical use of the patient prioritization tool.
Fatima Q. Alshaikhmubarak, Richard N. Keers, Petra Brown, Penny J. Lewis   +3 more
wiley   +1 more source

Real-World Experience with Isavuconazole for Invasive Aspergillosis in Hematologic Patients with and Without COVID-19 in Brazil. [PDF]

J Fungi (Basel)
Gandolpho LS, Ponzio V, Batista MV, França E Silva ILA, Ramos JF, Nucci M, Colombo AL.   +6 more
europepmc   +1 more source

Changes to Patterns of Oncology Medicine Dispensing in Response to the Onset of the COVID-19 Pandemic in Ireland: An Interrupted Time Series Analysis. [PDF]

Pharmacoepidemiol Drug Saf
Darragh IAJ, Mullooly M, O'Reilly D, Bennett KE.   +3 more
europepmc   +1 more source

Risk Factors for Seeking Medical Care Following Nirmatrelvir-Ritonavir (Paxlovid) Treatment for COVID-19: "Symptom Rebound". [PDF]

Viruses
Bhargava A, Szpunar S, Sharma M, Saravolatz L.   +3 more
europepmc   +1 more source

Efficacy and safety of casirivimab/imdevimab (REGEN-COV) in pregnant individuals with COVID-19: Literature review and insights from the COVID-19 International Drug Pregnancy Registry. [PDF]

Obstet Med
Wyszynski DF, Yau V, Keebler D, Renz C, Ives J, Fitzgibbon A, Shulman LP.   +6 more
europepmc   +1 more source

Digestive Manifestations of Post-COVID-19: A Focus on Therapeutic Strategies. [PDF]

Pathogens
Stasi C, Bellini M.
europepmc   +1 more source